• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Will Lowered Revenue Guidance Change Equifax (EFX) Narrative

    Simply Wall St·11/01/2026 07:27:07
    Listen to the news
    • Equifax reported third quarter 2026 revenue of US$1,692.5 million and net income of US$211.7 million, with higher basic and diluted EPS from continuing operations compared with the same period a year earlier, and also provided updated figures for the first nine months of 2026.
    • The company paired this earnings update with reduced full year 2026 revenue guidance, citing continued weakness in U.S. mortgage activity, while diversified markets guidance was maintained and fourth quarter revenue expectations were outlined.
    • This article will now examine how Equifax's investment narrative could be influenced by strong quarterly results alongside lowered full year guidance.

    Scan how Equifax's mix of strong reported earnings and softer guidance compares with other businesses facing similar crosswinds by reviewing the hand picked 29 resilient stocks with low risk scores in this space.

    Equifax Investment Narrative Recap

    To own Equifax, you need to believe the cloud and AI investments, Workforce Solutions verification engine and international operations can keep turning a growing data set into steadier earnings, even when mortgage volumes are soft. The latest quarter supports that story, with higher revenue, net income and EPS over both the quarter and first nine months of 2026.

    The near term swing factor is how long U.S. mortgage weakness weighs on U.S. Information Solutions and related verification activity, because that is what pushed management to trim full year revenue guidance. The key risk remains legal, regulatory and policy pressure around credit data and scoring, which can influence pricing, margins and product adoption.

    The most relevant update is the lowered full year 2026 revenue guidance to a midpoint of US$6.661b, reflecting weaker U.S. mortgage related business, while diversified markets revenue guidance was kept intact. That combination indicates the core verification and international pieces of Equifax appear more resilient than the mortgage exposed parts at the moment.

    For catalysts, that same guidance reset frames how to think about the upcoming fourth quarter revenue range of US$1.605b to US$1.635b. It provides a clearer bar to watch as Equifax promotes cloud based products, AI driven productivity and Work Number verification more deeply into employer, government and lender workflows while managing litigation costs and mortgage policy uncertainty.

    Equifax's projections estimate revenue of US$8.1b and earnings of US$1.2b by 2029, based on the company's stated assumptions. This is derived from an 8.0% yearly revenue growth rate and an earnings increase of about US$508.6m from earnings of US$691.4m today.

    Uncover how Equifax's fair value points to a 6% potential upside to its current price that could narrow quickly.

    NYSE:EFX 1-Year Stock Price Chart
    NYSE:EFX 1-Year Stock Price Chart

    Exploring Other Perspectives

    Three fair value opinions from the Simply Wall St Community bracket Equifax between roughly US$195 and US$442, with views spread fairly evenly across that range. That kind of gap shows how far private investors can diverge, especially when weighing litigation risk, mortgage market softness, and the potential payoff from cloud and AI driven efficiency gains. Readers should explore those contrasting viewpoints before deciding how Equifax fits into a wider portfolio.

    Explore 2 other Equifax fair value estimates, including one that suggests it could be worth just $195.10.

    Form Your Own Verdict

    Disagree with existing narratives? Extraordinary investment outcomes rarely come from following the herd, so consider developing your own view.

    Looking For More Investment Ideas Beyond Equifax?

    Once you have a handle on where Equifax fits in your portfolio, it can help to compare it with a few very different kinds of opportunities using the Simply Wall St Screener.